Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$5.3M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 11 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 35 most recent Form 4 transactions.
| Jun 18 | NVAX | Novavax INC | AGRANT◆ | 14,180 | — | — | — | Open the original filing on SEC.gov |
| Jun 18 | NVAX | Novavax INC | AGRANT◆ | 21,270 | — | — | — | Open the original filing on SEC.gov |
| Jun 16 | ARDX | Ardelyx, INC. | AGRANT◆ | 39,715 | — | — | — | Open the original filing on SEC.gov |
| Jun 16 | ARDX | Ardelyx, INC. | AGRANT | 26,455 | — | — | +0.8% | Open the original filing on SEC.gov |
| Jun 16 | ARDX | Ardelyx, INC. | AGRANT | 20,282 | — | — | +0.6% | Open the original filing on SEC.gov |
| Feb 20 | ARDX | Ardelyx, INC. | PBUY | 333,333 | $5.84 | $1.9M | +11.2% | Open the original filing on SEC.gov |
| Jan 6 | MRSN | Mersana Therapeutics, Inc. | DTOISS◆ | 2,200 | — | — | — | Open the original filing on SEC.gov |
| Jan 6 | MRSN | Mersana Therapeutics, Inc. | DTOISS◆ | 734 | — | — | — | Open the original filing on SEC.gov |
| Jan 6 | MRSN | Mersana Therapeutics, Inc. | DTOISS◆ | 1,800 | — | — | — | Open the original filing on SEC.gov |
| Jan 6 | MRSN | Mersana Therapeutics, Inc. | DTOISS◆ | 740 | — | — | — | Open the original filing on SEC.gov |
| Jan 6 | MRSN | Mersana Therapeutics, Inc. | DTOISS◆ | 1,002 | — | — | — | Open the original filing on SEC.gov |
| Jan 6 | MRSN | Mersana Therapeutics, Inc. | DTOISS◆ | 181 | — | — | — | Open the original filing on SEC.gov |
| Jan 6 | MRSN | Mersana Therapeutics, Inc. | DTOISS◆ | 368 | — | — | — | Open the original filing on SEC.gov |
| Jan 6 | MRSN | Mersana Therapeutics, Inc. | DTOISS◆ | 788 | — | — | — | Open the original filing on SEC.gov |
| Jan 6 | MRSN | Mersana Therapeutics, Inc. | DTOISS◆ | 1,000 | — | — | — | Open the original filing on SEC.gov |
| Jan 6 | MRSN | Mersana Therapeutics, Inc. | DTOISS◆ | 1,011 | — | — | — | Open the original filing on SEC.gov |
| Jan 6 | MRSN | Mersana Therapeutics, Inc. | DTOISS◆ | 400 | — | — | — | Open the original filing on SEC.gov |
| Jan 6 | MRSN | Mersana Therapeutics, Inc. | DTOISS◆ | 264 | — | — | — | Open the original filing on SEC.gov |
| Jan 6 | MRSN | Mersana Therapeutics, Inc. | DTOISS◆ | 2,460 | — | — | — | Open the original filing on SEC.gov |
| Jan 6 | MRSN | Mersana Therapeutics, Inc. | UTENDR | 383 | — | — | -100.0% | Open the original filing on SEC.gov |
| Jan 6 | MRSN | Mersana Therapeutics, Inc. | UTENDR | 23,546 | — | — | -100.0% | Open the original filing on SEC.gov |
| Jun 20, 2025 | NVAX | Novavax INC | AGRANT◆ | 18,884 | — | — | — | Open the original filing on SEC.gov |
| Jun 20, 2025 | NVAX | Novavax INC | AGRANT◆ | 28,326 | $6.42 | $181.9K | — | Open the original filing on SEC.gov |
| Jun 18, 2025 | ARDX | Ardelyx, INC. | AGRANT◆ | 54,059 | — | — | — | Open the original filing on SEC.gov |
| Jun 18, 2025 | ARDX | Ardelyx, INC. | AGRANT | 41,551 | — | — | +1.4% | Open the original filing on SEC.gov |
| Jun 18, 2025 | ARDX | Ardelyx, INC. | AGRANT | 31,163 | — | — | +1.1% | Open the original filing on SEC.gov |
| Jun 16, 2025 | ARDX | Ardelyx, INC. | PBUY | 200,000 | $3.63 | $725.9K | +7.4% | Open the original filing on SEC.gov |
| Jun 12, 2025 | NVAX | Novavax INC | MEXER◆ | 10,420 | — | — | — | Open the original filing on SEC.gov |
| Jun 12, 2025 | NVAX | Novavax INC | MEXER | 10,420 | — | — | +20.6% | Open the original filing on SEC.gov |
| Jun 12, 2025 | MRSN | Mersana Therapeutics, Inc. | AGRANT◆ | 61,500 | — | — | — | Open the original filing on SEC.gov |
| Jun 9, 2025 | ARDX | Ardelyx, INC. | PBUY | 200,000 | $3.69 | $737.3K | +8.0% | Open the original filing on SEC.gov |
| May 15, 2025 | ARDX | Ardelyx, INC. | PBUY | 100,000 | $3.29 | $329.1K | +4.2% | Open the original filing on SEC.gov |
| May 2, 2025 | ARDX | Ardelyx, INC. | PBUY | 381,377 | $4.22 | $1.6M | +18.9% | Open the original filing on SEC.gov |